The general surgery devices market is valued at USD 13.59 billion in 2025. As per FMI’s analysis, the industry will grow at a compound annual growth rate (CAGR) of 6.4%, reaching USD 25.26 billion by 2035.
The rise in demand for minimally-invasive procedures and progress in technology is anticipated to be the major driver for the industry growth, providing substantial growth opportunities in both developed and emerging industries.
Past years have witnessed an increase in the usage of cutting edge surgical technologies. The addition of robot-assisted surgery, direct energy technologies, and advanced imaging are bringing precision and patient quicker recovery. Major industry players, including Medtronic Plc, Stryker Corporation, B. Braun Melsungen AG, and Intuitive Surgical Inc. are taking the industry by storm with their novel product development efforts, and holding a strong stake.
According to FMI, the surge in chronic diseases requiring surgical intervention, combined with preference for minimally invasive surgeries will stay the leading growth factor of the surgical devices industry. However, expensive solutions, strict regulations, and the requirement for ongoing training for healthcare staff are projected to be major factors limiting the growth of the industry.
Addressing these challenges and having to find the balance between innovation and high standards will be very important for those that want to take advantage of new industry opportunities.
The industry also sees opportunities in developing economies with rapidly improving healthcare infrastructure. Industries in regions namely Asia-Pacific and Latin America have immense growth opportunities, arising from greater healthcare spending and accessibility to modern medical technologies.
Industry Forecast Table
| Metric | Value |
|---|---|
| Industry Value (2025E) | USD 13.59 Billion |
| Industry Value (2035F) | USD 25.26 Billion |
| CAGR (2025 to 2035) | 6.4% |
The market is growing because of the advancements in technology. With the introduction of robot-assisted, direct energy applications, and improved imaging, procedures have entered the revolutionizingphase where precision in surgery is increased and patient recovery times are decreased. This trend towards advanced technologies is generating the need for new surgical instruments.
Rising healthcare spending across the world is also one of the key drivers of market growth. Both public and private healthcare investors are providing more investment into healthcare infrastructure, specifically in the developing world. This increase in healthcare access supports the penetration of sophisticated surgery devices which is helping the market grow worldwide, especially in APAC and LATAM regions.
Increasing prevalence of chronic diseases such as cancer, cardiovascular, and gastrointestinal diseases is further driving demand in surgical procedures. These diseases frequently necessitate challenging operations, which tend to stimulate the demand for sophisticated surgical instruments. This development, along with the aging worldwide population, supports the demand for premium devices.
While the future looks bright, the high cost of many modern-day devices can prevent their access in cost-sensitive industries. Therefore, companies need to consider competitive options for durable solutions, which are economically viable without negotiating quality, if they want to enter into new industries and serve a larger patient population.
The sector is influenced by several stakeholders who have unique roles in the value chain. Manufacturers stimulate market growth by focusing on innovation and product development in response to increasingly complex performance, safety, efficiency and cost reduction needs.
Hardware providers team up with tech players to embed sophisticated robotics, imaging and AI that can expand the capabilities of surgical devices and improve patient outcomes. Their success is premised on good long term supplier relationships (for high grade materials and components) as well as the processing conditions that ensure parts meet regulatory requirements.
Tech companies, such as software developers and hardware engineers, can help drive the evolution of surgical instruments. These are the forces working on creating systems that are behind innovations in robotic surgeries, real time imaging and AI diagnostics. Their work in the market helps to keep manufacturers ahead of the competition and breaking old barriers in terms of what today’s surgical devices can accomplish.
Venture capitalists and institutional investors both play a major role influencing the growth of market. They provide funds to support research, development, and expansion so that manufacturers can take the next steps in cutting-edge technologies. Investors also pay attention to industries to spot opportunities for big returns, driving a demand for faster implementation of new technologies.
The robotic-assisted surgical systems are anticipated to have the highest growth rate among all product categories, and a CAGR of about 10% between 2025 and 2035. The use of robotic-assisted surgical systems is increasing mainly because of growing demand for minimally invasive procedures.
The systems allow surgeons to conduct intricate procedures more precisely, flexibly, and under their control compared to traditional methods. Patients bear less pain, smaller cuts, reduced hospital stays, and faster recovery, which has promoted higher acceptance among healthcare providers as well as patients.
In addition, advances in robotic technology such as enhanced imaging, real-time data integration, and artificial intelligence are increasing the reliability and availability of these systems. The worldwide increase in chronic diseases, an aging population, and the increasing number of surgeries being conducted globally also add to the growing market. Hospitals are now spending more on robotic systems to enhance surgical outcomes, recruit top talent, and stay competitive in a fast-changing healthcare landscape.
The bariatric surgery is projected to grow at a CAGR of 7% during 2025 to 2035. It will be driven by an increasing number of people seeking weight loss interventions against obesity and its comorbidities. General surgery equipment is commonly used in this surgery for carrying out a range of intricate procedures involving the gastrointestinal tract.
The equipment staplers, energy devices, laparoscopes, and suture tools are all tailored specifically to deal with sensitive tissues while providing accuracy in incisions, resections, and closures. Bariatric procedures like gastric bypass, sleeve gastrectomy, and adjustable gastric banding necessitate equipment that can support minimally invasive procedures with safety and efficacy.
The ambulatory surgical centers (ASCs), accounted for a revenue share of approximately 40% in 2025 and are projected to witness an impressive CAGR of 8% over the assessment period on the back of rapidly increasing trend of outpatient surgeries. Ambulatory surgical centers (ASCs) are principal end users of devices because they can effectively and economically conduct a variety of outpatient surgical procedures.
These facilities are specifically for same-day discharge, enabling patients to go home soon after their procedure. Consequently, there is a high need for general surgery equipment that can be used to sustain minimally invasive procedures, which are faster, less traumatic, and have shorter recovery periods. Equipment like laparoscopic instruments, electrosurgical equipment, and suturing instruments are instrumental in carrying out such procedures.
The USA is projected to be the fastest growing market during 2025 to 2035 with a CAGR of 6.5%. Owing to advanced healthcare infrastructure and high surgical procedures being conducted, the USA continues to play a major role in the global market.
The role of technology in the form of robot assisted surgery and minimally invasive devices is likely to improve surgical outcomes and decrease recovery periods. The growing geriatric population and increase in the prevalence of chronic diseases demands for devices. Medtronic, Stryker, Johnson & Johnson and other leading players have a heavy focus on innovation to respond to the ever-increasing requirements.
The general surgery devices market is projected to expand at a CAGR of 6.2% during 2025 to 2035 in the UK. The UK healthcare system, and in particular the National Health Service (NHS) is increasingly integrating advanced surgical technology into clinical practice to enhance patient care.
According to FMI’s analysis, increasing preference for minimally invasive surgery approach in bariatric and colorectal surgery willstimulate market growth. In the private sector, robotic assisted services are also being included by private health institutions. But tight budgets and financial realities in the NHS could present challenges to an expedited rollout of state-of-the-art technologies. Notwithstanding the above, the UK is still an attractive market for general surgery equipment.
The France is estimated to grow at 5.8% CAGR from 2025 to 2035 in the general surgery devices market. According to FMI’s analysis, the country’s healthcare market is growing due to swirling medical device implants and the market concentrating more on the minimally invasive surgeries for enhancing the patient recovery time and reducing hospital stay. Growth in the number of lifestyle diseases along with the growing aging demographic will expectedly cause the demand for general surgery device to be on the high side.
According to FMI, robotic surgery and laparoscopic devices are projected to preside over the market, however, it faces obstacles in the terms of stringent government regulation and cost economies market.
The Germany market, is projected to grow at a CAGR of 6.1% from 2025 to 2035. Germany is home to one of Europe´s most modern healthcare systems which offers a solid base for the further development of the market. FMI has projected that there will be an increasing interest in next-generation surgical technology, with a focus on robotic-assisted surgery, as well as highly advanced energy-based devices.
An increasing geriatric population in the country and high incidence of chronic diseases will further drive the demand for surgeries in segments such as the colorectal and bariatric surgeries. Challenges, however, high cost and strict regulations for the medical devices could hinder the market growth.
The Italy market is projected to grow at a CAGR of 5.7% from 2025 to 2035. According to FMI’s report, Italy’s health market is more serious about advanced surgical treatments, which include robotic and minimally-invasive surgeries. Increasing surgical volume, especially in general and colorectal surgeries will be a key factor driving market growth.
The FMI also finds strong demand for laparoscopes and diagnostic devices. Yet budget cuts in public healthcare and different acceptance levels in different regions, are barriers to growth. However, Italy’s large manufacturing base of medical devices should have a positive impact on the market.
The South Korea is projected to be the fastest growing market with a CAGR of 7.0% from 2025 to 2035 in general surgery devices. According to the findings of FMI, South Korea’s healthcare system is considered as high quality and innovative. Rising need for robotic-assisted surgery and minimally invasive instruments will propel the growth across the market.
With strong medical care set up and government support towards medical technology adoption, the country has a strong healthcare infrastructure and government support for medical technology adoption which is supplementing the market growth. The market growth can further be credited to the increasing penetration of premium surgical devices in South Korea In both public and private sectors.
The Japan market size is estimated to register a CAGR of 6.3% from 2025 to 2035. According to FMI, advanced healthcare infrastructure in Japan combined with an increasing elderly population would make the country an important market. The uptake of robotic-assisted surgical transactions is increasing, especially in laparoscopic settings, as the country continues to modernize its surgical practices.
Furthermore, the proliferation of advanced medical technologies in Japan will be a major market booster. But high costs of medical devices and competitive nature of the market may decelerate rate of market penetration for new technology.
The China is projected to grow at a CAGR of 7.5% during 2025 to 2035 in the market. According to FMI, China's vast aging population offers ample opportunities for the general surgical devices market. Growing support to healthcare infrastructure and rising interest for advanced surgical tools including minimally invasive and robotic-assisted surgery will boost demand.
The Chinese government focuses on modernizing its healthcare market, which will create a conducive market atmosphere for expansion. Nonetheless, regulatory barriers and economic difficulties associated with advanced technology implementation may slow down the expansion.
The New Zealand is estimated to grow at a CAGR of 5.2% in the market between 2025 and 2035. FMI’s findings indicate that New Zealand has implemented advanced surgical technology despite having a smaller healthcare infrastructure than other countries. The increase in minimally invasive procedures will drive growth.
However, New Zealand's small population and market size may present challenges in scaling up some surgical technologies. As per FMI analysis, focus of country towards enhancing patient outcomes will emerge as a chief growth influencing factor, in-spite of the restraints.
The Australia general surgery devices market is anticipated to see a CAGR of 6.0% in the market between 2025 and 2035. FMI’s report also predicts that market in Australia is gaining traction on the back of well-established healthcare sector considering as one of the advanced in the region. Increased emphasis on minimally invasive procedures and advances in robotic surgery will spur demand for novelty surgical instruments.
The growing geriatric population and high prevalence of lifestyle diseases will continue to drive the market growth. Yet cost and the approval of new technologies could pose hurdles. Notwithstanding these, Australia’s healthcare is still a prime market in the region.
In 2024, Medtronic (20-25% market share) led with its advanced robotic-assisted surgical systems, enhancing precision in minimally invasive surgeries. Stryker Corporation (15-20%) strengthens its position with the acquisition of Vapotherm, expanding its portfolio in robotic surgery. Johnson & Johnson (18-22%) focuses on innovation with the launch of a new robotic surgical system aimed at improving surgical outcomes.
Boston Scientific Corporation (10-15%) makes strides in AI-driven surgical solutions, improving surgical efficiency. Olympus Corporation (7-10%) introduces next-generation endoscopy systems, advancing minimally invasive procedures. Zimmer Biomet (5-8%) enters the robotic surgery market with a new system, further expanding its reach.
Becton Dickinson (5-8%) enhances its role in laparoscopic surgeries with new access devices. Smith & Nephew (4-6%) strengthens its product lineup, focusing on internal closure devices. These developments highlight a continued focus on technological innovations in robotic surgery, endoscopy, and AI-driven solutions, positioning these companies for growth and market leadership in the general surgery devices sector.
| Company Name | Market Share |
|---|---|
| Medtronic | 20-25% |
| Stryker Corporation | 15-20% |
| Johnson & Johnson | 18-22% |
| Boston Scientific Corporation | 10-15% |
| Olympus Corporation | 7-10% |
| Zimmer Biomet | 5-8% |
| Becton Dickinson | 5-8% |
| Smith & Nephew | 4-6% |
Key Strategies of General Surgery Devices Manufacturers, Suppliers, and Distributors
The key players in the general surgery equipment market are concentrating on new product launches and upgrading the existing product technology. To meet the increasing demand for minimally invasive procedures, numerous entities are widely investing in robot assisted systems and AI powered solutions.
The other emphasis will be on strategic collaborations with tech suppliers to bring in cutting-edge technologies to their products. Manufacturers are moving out geographically, reaching out to new industries, which are emerging industries for high-end medical devices. This growth model allows them to take advantage of unfilled opportunities and to build a portfolio of revenue streams.
That’s especially true for investors who are backing companies that are focusing on innovation and sustainable growth. They are pouring capital into companies targeting regulation-compliance and product development for the changing needs within the healthcare sector.
Strategically, businesses involved with other minimally invasive surgery technologies and robotic systems that are at an expansion stage also are considered high-value opportunities. Moreover, investors are pressuring companies to take actions that would improve operational efficiencies, cut costs, and gain market share.
Policymakers greatly influence the competitive landscape of the market. With rising demands for higher standards of healthcare and patient safety, the regulatory authorities are tightening approval procedures for small volume parenteral drugs.
Consequently, market groups are collaborating with regulators to ensure their products can live up to the high standards of safety and effectiveness that drugs are held to. Manufacturers are pushing for a more unified approach to approval, while also seeking to get ahead of modifying regulations for data privacy, cybersecurity and clinical testing.
End-users such as hospitals, ambulatory surgical centers, and clinics seek cost-effective and quality devices for general surgery. To address this need, providers of care are increasingly embracing value-based pricing models and seeking insight to enhance surgical outcomes with technology-based solutions.
The focus is on the devices that save money in the long run, and that promise quick returns to health and minimized complications. End-users are working together with manufacturers to develop individual products based on procedural requirements to improve patient care.
The major success factors in the general surgery devices market is attributed to advancements in technology, and increasing preference for minimally invasive surgeries. With such increasing demands for faster recovery times, shorter hospital stays and increased surgical precision, the market is being driven to develop more sophisticated systems such as robotic assisted surgical systems and AI based solutions.
They are not only improving the lives of patients, they are also increasing the efficiency of healthcare systems. In addition, new imaging and real-time data analysis are a critical force in assisting the success of surgical devices, giving the surgeon added visualization and decision support tools.
The increased significance of regulation compliances and safety standards is yet another critical factor. As patient safety and care quality are becoming increasingly important, manufacturers are subject to strict regulations to guarantee their devices conform to safety standards all over the world.
In terms of product, the industry is segmented into direct energy system devices, trocars/access devices, internal closure devices, laparoscopes, hand access instruments, insufflation devices, and robotic assisted surgical systems.
By application, the industry is segmented into bariatric surgery, colorectal surgery, general surgery, gynaecological surgery, and other surgery.
Based on end user, the industry is segmented into hospitals, ambulatory surgical centres, and clinics.
Regionally, the industryis studied across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa (MEA).
The growth of the general surgery devices industry is driven by increasing demand for minimally invasive procedures, technological advancements in robotic surgery systems, and the growing prevalence of chronic diseases that require surgical intervention.
Regulatory changes are pushing for stricter safety standards and greater transparency in device manufacturing. This leads to the adoption of more advanced and reliable surgical devices that comply with new medical device regulations.
Technological innovations such as robotic-assisted surgery systems, advanced laparoscopes, and improved energy-based devices are transforming the industry, enabling more precise and less invasive procedures.
North America, Europe, and Asia-Pacific are expected to see the highest demand, driven by advancements in healthcare infrastructure, increasing surgical procedures, and the adoption of cutting-edge technologies.
Manufacturers face challenges such as rising production costs, the need for continuous innovation to stay competitive, and navigating the complex regulatory environment to bring new products to industry while ensuring safety and efficacy.
Explore Therapeutic Device Insights
General Surgery Devices Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
